Cotinga Pharmaceuticals Inc. Share Price Toronto S.E.
Equities
COT
CA22675B2021
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | -41.67% | -22.22% | -41.67% |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.2M 135M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.47M -334M | Net income 2019 | -2M -2.73M -167M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 55.65K 3.4M | Net cash position 2019 | 24.64K 33.67K 2.06M | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
1 day | -41.67% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01/15/01 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12/17/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/18/01 | |
John C. Drake
CHM | Chairman | - | 20/07/20 |
Alison D. Silva
PSD | President | 46 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-2.68% | 21.93B | |
-5.61% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- COTQF Stock
- COT Stock